Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VRTX
Stock Latest News
The Fly
Vertex Pharmaceuticals, WuXi Biologics enter license and research service pact
16h ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
5d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays
7d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $545 from $535 at UBS
9d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI
12d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals gets orphan status for membranous nephropathy treatment
12d ago
VRTX
Premium
The Fly
Vertex upgraded to Outperform from Sector Perform at RBC Capital
13d ago
VRTX
Premium
The Fly
Maze Therapeutics price target raised to $46 from $37 at BTIG
15d ago
MAZE
VRTX
Premium
The Fly
Bernstein upgrades Vertex, names top 2026 biotech pick
22d ago
VRTX
Premium
The Fly
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
23d ago
VRTX
Premium
Company Announcements
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story
26d ago
VRTX
Premium
The Fly
Sionna Therapeutics price target raised to $58 from $50 at BTIG
27d ago
SION
VRTX
Premium
The Fly
Vertex Pharmaceuticals assumed with a Buy at UBS
28d ago
VRTX
Premium
The Fly
Wolfe upgrades Vertex Pharmaceuticals, says ‘may be due for a rebound’
29d ago
VERA
VRTX
Premium
The Fly
Vertex Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
29d ago
VRTX
Premium
Stock Analysis & Ideas
Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26
29d ago
CI
VRTX
Premium
Market News
BofA Rolls Out “Top 10 Ideas” for 1Q26 Across Key Sectors
1M ago
BA
CI
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
1M ago
BA
CI
Premium
The Fly
BofA lays out Top 10 U.S. ideas for Q1
1M ago
BA
CI
Premium
The Fly
Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink
1M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
1M ago
VRTX
Premium
Ratings
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
2M ago
VRTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
